⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of MediLink Therapeutics and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
MediLink Therapeutics
↗Suzhou, China
MediLink Therapeutics is a clinical-stage biotechnology company founded in 2020, specializing in the development of next-generation antibody-drug conjugates (ADCs). The company has developed a proprietary Tumor Microenvironment Activable LINker-payload (TMALIN®) technology platform, which is designed to generate homogeneous ADCs with improved therapeutic windows for the treatment of solid tumors.
Headquartered in Suzhou, China, with R&D subsidiaries in Shanghai and Boston, MediLink focuses on addressing unmet medical needs in oncology. The company has established significant global partnerships, including major licensing agreements with Roche and BioNTech, to advance its pipeline of ADC candidates.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Founded:2020
Ownership:private
Status:operating
FUNDING
Stage:Series B
Total Raised:$120M
Investors:LYFE Capital, Qiming Venture Partners, Legend Capital, Loyal Valley Capital, Highlight Capital (HLC)
PIPELINE
Stage:Phase 2
Lead Drug Stage:Phase 3 (YL201)
Modalities:Antibody-drug conjugate (ADC), Dual-payload ADC, Molecular glue-antibody conjugate
Active Trials:23
Trial Phases:Phase 1: 1 | Phase 2: 1 | Phase 3: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:MediLink Therapeutics (Shanghai), MediLink Therapeutics (Boston)
Key Partnerships:Roche (Collaboration for YL201 and YL211), BioNTech (Collaboration for HER3-targeting ADC)
COMPETITION
Position:Emerging
Competitors:Oxford Biotherapeutics
LEADERSHIP
Key Executives:
Tony Xue - Chairman, Founder & CEO
Jiaqiang Cai - Co-founder, CSO & Co-CEO
Weichang Zhou - CTO
LINKS
Website:medilinkthera.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with MediLink Therapeutics. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.